Blog Articles

Transplanting young stem cells extended old mice's lifespan by 28%, suggesting a path to human rejuvenation.

Young donor stem cells improve frailty in a clinical trial: What if they had their own younger cells. In my last blog post, I discussed our plan to transplant our own younger mesenchymal stem cells (MSCs) to our older selves for the purposes of rejuvenation.

Mark Katakowski, President of Forever Labs, presents a Talk at Google on how stem cell rejuvenation could potentially increase human life expectancy by restoring the function of aging

DigitalCulture.LA's Brittney Gallagher interviews Forever Labs co-founders Steven Clausnitzer and Mark Katakowski on Forever Labs co-founders on adult stem cell storage. The core message: Cryopreserve your healthy stem cells now to "lock in" their youthful vigor before they age, preparing for future medical needs.

Three Questions As CEO of Forever Labs, I attend as many of our stem cell collections as I can and I talk with many of our clients. The majority of people that are interested in storing their young-adult stem cells with us have the same three questions.

Forever Labs physician Dr. Michael Schenden featured on WXYZ Detroit news Last week, Dr.

Why Your Own Cells Matter While donor products could offer temporary relief, your own cryopreserved stem cells can provide a lasting solution for tissue repair. By avoiding immune rejection, "self" cells can fully integrate and heal your body long-term. Learn why storing your youngest and most viable stem cells cells is your best healthcare asset.

Do MSCs act exclusively on the immune system in neural injury. An interesting study came to my attention recently.

Cellular Senescence in Brief Forever Labs was founded on the principle that each of us has a valuable reservoir of bone marrow cells, and that as we age this reservoir is depleted, much like an extended drought that has depleted Lake Powell in the Southwest. Las Vegas and Phoenix grow and grow, it rains less and less, and the river can’t keep the water level high enough to meet demand. I think this is a salient analogy of what happens in our bone marrow as we age.

Stanford University researcher Tony Wyss-Coray explores groundbreaking research into how young blood and cellular factors can potentially reverse the effects of aging on the human brain and body. This insight into regenerative medicine suggests that internal biological triggers may be the key to revitalizing cognitive health and physical longevity.

New Studies Show How Donor Age Affects MSCs’ Disease Fighting Capabilities In the past, I’ve written that there is a strong suggestion that MSCs from older individuals are less likely than those from young ones to fight diseases, but that the evidence—though strong—is mainly circumstantial. However, two very recent studies have shown direct and convincing evidence that this is indeed the case.

Bone marrow vs. adipose MSCs There is an ongoing debate among stem cell therapy proponents about what the best source of cells is.

What is a stem cell anyway. As a biologist, and one who works with bone marrow stem cells in daily life, it’s easy to forget that to the general public, a ‘stem cell’ is not much more than an abstraction, a news-worthy meme that comes light on the details.

What happens to your cells as they age. The answer is complex and imperfectly understood.

Aren't iPS cells the future. When talking to friends, colleagues, and others about Forever Labs, those among them with a certain level of knowledge in the biosciences often turn the conversation to iPS cells.

Recent research in gerontology shows that injecting young bone marrow into older mice can increase their remaining lifespan by up to 39%. While these findings highlight the exciting potential of regenerative medicine for life extension, further study is needed to determine how these biological mechanisms translate to human aging.

Forget aging by accident. Forever Labs lets you bank your younger stem cells today to fuel your health tomorrow. Because when it comes to your biology, your best donor is a younger version of you.

PCOS (primary topic) and emerging stem cell-based treatments (MSC, extracellular vesicles, exosomes), including a human case report and ongoing clinical trials. It emphasizes fertility/reproductive implications, metabolic (insulin resistance) aspects of PCOS, and the proposition of banking stem cells.

Muse stem cells are naturally occurring, stress-resistant pluripotent cells that can home to damaged tissues and regenerate without forming tumors, making them a promising and safer option in regenerative medicine. Early clinical trials target

This large single-center study looked at outcomes when people with relapsed multiple myeloma received a second autologous hematopoietic cell transplant (autoHCT) either later in their disease course ("delayed") or as a planned salvage treatment. The team reviewed 650 patients treated from 2006–20...

MSC-derived exosomes (tiny cell-made vesicles) can cross the blood–brain barrier and deliver regenerative signals that MSCs themselves can’t. In animal Alzheimer’s models, they boosted neurotrophic factors like BDNF and NGF (supporting neuron growth/survival), reduced pro-inflammatory molecules, and were associated with less amyloid plaque buildup and better performance on memory/cognition tasks. Early human trials are still small and preliminary, but so far look generally tolerable and show hints of reduced inflammation—meaning it’s promising, but not yet proven or ready as a standard treatment.

Stem cell research is transitioning from theory to clinical reality, with over 750 recent trials targeting conditions like osteoarthritis and heart disease. While global adoption grows, many Americans remain hesitant due to common misconceptions. Self-derive stem cell therapy is legal in the U.S. when minimally manipulated, poses low rejection risks, and avoids ethical issues by using adult cells rather than embryos. Compared to surgery, these treatments are minimally invasive with faster recovery times. Companies like Forever Labs now offer biobanking, allowing individuals to preserve their young cells for future longevity treatments.

As of early 2026, the landscape for regenerative medicine has undergone a transformative shift, moving from a period of experimental storage to one of clinical accessibility. For individuals who have invested in stem cell banking, the bridge to active therapy is now open, supported by landmark state legislation and new domestic manufacturing capabilities.

Why freezing your young stem cells matters today. Bank your young Mesenchymal Stem Cells (MSCs) today to secure a high-potency, genetically-matched 'medical reserve' for your future. Research shows that younger MSCs offer enhanced healing, boost cognitive function, and are linked to extended healthspan, providing an ideal resource for future regenerative therapies while eliminating the risk of immune rejection.

Explore Forever Labs's outlook on 2026 trends in regenerative medicine. Longevity has transitioned from biohacking to a mainstream standard of care. Discover breakthroughs in "bio-liquidity", MSC priming, and epigenetic resetting, alongside regulatory shifts in the United States empowering patients to own their biology.

Beast Games star and matchmaker Tessa Mac shares her powerful journey into regenerative medicine, sparked by a friend’s cancer battle and solidified by her own "aha" moment regarding biological insurance. In the inaugural episode of Future Proof with Forever Labs podcast, she shares why she decided to freeze her Mesenchymal Stem Cells (MSCs) as the ultimate "low-hanging fruit" for long-term health. From setting world records to surviving California wildfires, Tessa explains how securing her youngest, healthiest cells allows her to live a high-octane life today with zero regrets for tomorrow.

MSC Therapy for Heart Disease: Regenerative approach with Mesenchymal Stem Cells to restore cardiac function. Studies like DREAM-HF show a 58% reduced risk of heart attack, moving beyond symptom management.

Wyoming’s Senate File 48, the Stem Cell Freedom Act, proposes a legal framework for physicians to perform autologous stem cell therapies under IRB oversight and cGMP safety standards.

In the latest Future Proof with Forever Labs episode, Dr. Trevor Turner shares the latest on regenerative orthopedics at CartiNova. Discover how to move beyond pain management to genuine joint repair, securing lifelong mobility with banked stem cells and more.

Forever Labs CEO Kevin Virgil avoided knee surgery by using his own banked stem cells to treat osteoarthritis, returning to trail running and proving the power of biological insurance.

Mary Shaver, a 35-year-old nurse, shares her experience banking her stem cells with Forever Labs. She details why she chose to preserve her youth today to protect her health for the future.

Discover how Forever Labs and Michigan Center for Regenerative Medicine are growing access to advanced stem cell storage and expansion to the U.S., offering personalized, high-dose regenerative treatments for long-term joint health and recovery.

On the Future Proof with Forever Labs podcast, Drs. Tad DeWald and Brett Fox talk about proactive prehab and regenerative medicine. They promote a 50/50 partnership between clinical care and personal movement to future-proof your physical health.

From CRISPR to cord blood, explore how six women are pioneering and moving medicine toward a proactive, evidence-based future of recovery.

Turn your aesthetic procedure into a milestone for longevity. Discover how to bank your own stem cells during liposuction or skin reduction to power your future health and healing.

Japan conditionally approves stem cell treatments for Parkinson’s and heart failure. Clinical trials show significant functional recovery, shifting from managing symptoms to restoring health.

RYC Orthopaedics PA Jenna Trainor on regenerative medicine, orthobiologics, and proactive care with Forever Labs

Saving your body's repair cells just got much easier. A new partnership makes it

A study published in Bone found that stem cells from younger donors could divide more times, divided faster, and showed signs of cellular aging later than cells from older donors. While the study was small and conducted in the lab, it highlights a fundamental idea: our stem cells age with us—and we can’t go back later to recover the younger cells we once had.